Overview

Join Us for the Ten Year Special Planning Anniversary at DIA China 10th Annual Meeting
Every year at May, the DIA China Annual Meeting, which includes the whole chain of drug R&D and focuses on clinical and regulatory science, has become the most important opportunities to exchange ideas and practices, expand network and display products & services in China healthcare community.
The 10th DIA China Annual Meeting from May 22-25, 2018 will bring together more than 2000 pharmaceutical R&D professionals from different continents and regions, involved at all levels of the health care product development spectrum, to discuss recent and upcoming transformational changes for China’s innovation and regulatory environments.
Special DIAmond Sessions will introduce global views into our perspective of the Chinese pharmaceutical ecosystem. Sessions will model the experience from the global DIA 2017 Annual Meeting in the US. As the largest multidisciplinary event in DIA Asia, other highlights will include 100+ exhibit booths and a new, unique hub for R&D and emerging companies to showcase themselves in “Innovation Hub.”
Professionals involved at all levels in the regulation, discovery, development, and life cycle management of health care products, will travel from China and around the world to witness transformational changes for China’s innovation and regulatory environment, to share the view points, knowledge, new technologic progress, and cross-cutting collaboration towards patient centric biopharma innovation in China.
Program Committee
-
Pei HU Director, Phase I Unit, Clinical Pharmacological Research Center
Peking Union Medical College, China -
Bin Xue Director-General
China Center for Food and Drug International Exchange, NMPA, China -
Xiaojun (Wendy) Yan, MD, MBA Senior Vice President, Senior Advisor
BeiGene (Beijing) Co., Ltd., China -
Irene Deng Head of Regulatory Affairs, China
Sanofi, China -
Jin Cui Program Officer
China Center for Food and Drug International Exchange , China -
George LIU Head of Early Development and Scientific Operation
Harbour Biomed, China -
Zhiqiang Ning Vice President, Research & Clinical Development
Shenzhen Chipscreen Biosciences, Ltd., China -
Jessica Liu, MD Senior Consultant
Beijing Taya Ltd, China
Have an account?